In addition, a group of researchers detected the serum levels of lncRNAs PVT1, HOTAIR, NEAT1, and MALAT1 from Egyptian breast cancer and fibroadenoma patients, as well as healthy donors, and found that serum PVT1, HOTAIR, and NEAT1 could serve as potential biomarkers for breast cancer. Here, MALAT1 is linked to breast carcinoma.